PanoramicaGraficoNotizieSchermataTrader

Soc. Generale Knock-Out HSI.X/  DE000SU027Q4  /

EUWAX
14/05/2024  15:32:00 Var.-0.22 Denaro15:51:53 Lettera15:51:53 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
8.60EUR -2.49% 8.55
Quantità in denaro: 50,000		 8.60
Quantità in lettera: 50,000		 Hang Seng Idx. 11,863.2426 - 31/12/2078 Call
GlobeNewswire 16:07 StakingFarm CEO Addresses Concerns Over SEC’s Potential Crackdown on Crypto Staking
GlobeNewswire 16:05 Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at ...
GlobeNewswire 16:05 Franklin Energy Partners with the New Mexico Energy, Minerals, and Natural Resources Department to I...
GlobeNewswire 16:03 Dr. Nikolas Tsakos, Founder & CEO of TEN Ltd. Interview Today Live at NYSE – Schwab Network
GlobeNewswire 16:03 Avantax Planning Partners Recognizes Affiliate Accomplishments, Builds on Strong CPA Firm Relationsh...
GlobeNewswire 16:00 Trust Stamp Provides a Business Report and Financial Results for the Three Months Ended March 31, 20...
Newsfile Corp 16:00 Commencis Launches New Turkish LLM Targeting Banking and Financial Services
Newsfile Corp 16:00 Bionic Power Launches $500,000 Agilik Movement Campaign on GoFundMe
Newsfile Corp 16:00 Vedomi-Hydrogen and GreenEarthX to Revolutionize Offtake Market for Green Hydrogen and Derivatives, ...
GlobeNewswire 16:00 New to The Street TV Signs Greene Concepts, Inc. to a 6-Part Media Series, Contract Includes Digital...
GlobeNewswire 16:00 Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European...
GlobeNewswire 16:00 Draper University To Invest in the Stellar Ecosystem with New Accelerator Programs Focused on AI and...
GlobeNewswire 16:00 Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
GlobeNewswire 16:00 Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT...
GlobeNewswire 16:00 Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
GlobeNewswire 16:00 MedSource Labs Announces Innovation in Safety, Accuracy and Functionality of IV Catheters
GlobeNewswire 16:00 IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
GlobeNewswire 16:00 Gateway Group Awarded Highest Honor by Hermes Creative Awards in Strategic Public Relations Category...
GlobeNewswire 16:00 Great Escapes RV Resorts Bryan-College Station Brings Next Generation Family Vacations to Texas
GlobeNewswire 16:00 Garrett Damore Leaves Davidoff to Join El Septimo Cigars
GlobeNewswire 16:00 Queen’s U Students Give Residence Cleaning an A+
GlobeNewswire 16:00 Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the Europea...
GlobeNewswire 16:00 Ultimus Supports Launch of CAZ Strategic Opportunities Fund
GlobeNewswire 16:00 Nurix Therapeutics Announces Upcoming Oral Presentation of New Data from Ongoing Clinical Trial of N...
GlobeNewswire 16:00 Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association